Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11

Trial Status

Completed3
Other2

Role Distribution

Principal Investigator5
PI Rate100%

Activity Timeline

Clinical Trials (5)

NCT02559349Completed
Gut Microbiota And Radiotherapy
Lung Tumor
PrincipalinvestigatorStart date: 2015-09-01
NCT01918683Not ApplicableActive Not Recruiting
TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients
Hepatocellular Carcinoma
Principalinvestigator
NCT01985958Not ApplicableCompleted
A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas
Histological or Cytological Diagnosis of Pancreatic Carcinoma
Principalinvestigator
NCT02207465Phase 1Active Not Recruiting
A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer
Borderline Resectable Pancreatic Cancer Treated With ChemoradiotherapyLocally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
Principalinvestigator

Research Network

Collaboration Network

2 collaborators·1 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Tarita Thomas, MD, PhD

Loyola University

Related
1 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular

Worked with same sponsors:

Abramson Cancer Center at Penn MedicineLoyola University+1 more
Collaborated on 1 trial
Similarity Score14%

Ajay Goel, PhD

City of Hope Medical Center

Related
24 trials

Shared therapeutic areas:

Cancer of EsophagusCarcinoma, Hepatocellular
Similarity Score10%

Zhenfeng Zhang, MD, PhD

Second Affiliated Hospital of Guangzhou Medical University

Related
21 trials

Shared therapeutic areas:

Carcinoma, HepatocellularCancer of Esophagus
Similarity Score10%

Michael B Gill

Power Life Sciences Inc.

Related
105 trials

Shared therapeutic areas:

Cancer of EsophagusCarcinoma, Hepatocellular
Similarity Score10%

Jeong Min Lee, MD

Seoul National University Hospital

Related
34 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score5%

John D. Hainsworth, MD

SCRI Development Innovations, LLC

Related
26 trials

Shared therapeutic areas:

Cancer of Esophagus
Similarity Score5%

Deborah E Citrin, M.D.

National Cancer Institute (NCI)

Related
13 trials

Shared therapeutic areas:

Cancer of Esophagus
Similarity Score5%

Robert L. DeJager, MD, FACP

Daiichi Sankyo

Related
13 trials

Shared therapeutic areas:

Cancer of Esophagus
Similarity Score5%

Xiaoli Lan, PhD

Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

Related
16 trials

Shared therapeutic areas:

Cancer of Esophagus
Similarity Score5%

Saleh K Saleh, MD

Minia University

Related
23 trials

Shared therapeutic areas:

Carcinoma, Hepatocellular
Similarity Score5%

Publications (0)

No publications found for this investigator.

Clinical Trials (5)

Showing 5 of 5 trials

NCT03151642PrincipalInvestigator

A PILOT STUDY OF DIFFUSION WEIGHTED MRI TO ASSESS ESOPHAGEAL TUMOR RESONSE TO NEOADJUVANT CHEMORADIATION

Esophageal Cancer
Completed
NCT02559349PrincipalInvestigator

Gut Microbiota And Radiotherapy

Lung Tumor
Completed
NCT01918683Not ApplicablePrincipalInvestigator

TACE With or Without SBRT as Bridging Therapy for Pre-transplant HCC Patients

Hepatocellular Carcinoma
Active Not Recruiting
NCT01985958Not ApplicablePrincipalInvestigator

A Pilot Study to Evaluate Radiotherapy-Induced Anti-Tumor Immunity in Metastatic Carcinoma of the Pancreas

Histological or Cytological Diagnosis of Pancreatic Carcinoma
Completed
NCT02207465Phase 1PrincipalInvestigator

A Phase I Dual Dose Escalation Study of Radiation and Nab-Paclitaxel in Patients With Unresectable and Borderline Resectable Pancreatic Cancer

Borderline Resectable Pancreatic Cancer Treated With ChemoradiotherapyLocally Advanced Unresectable Pancreatic Cancer Treated With Chemoradiotherapy
Active Not Recruiting

All 5 trials loaded